Dr Reddy’s partners with BIRAC for Sputnik V clinical trials in India
The partnership will allow Dr Reddy’s to identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BIRAC
CSIR and Aurobindo Pharma to collaborate for COVID-19 vaccine development
DBT is also supporting Aurobindo Pharma’s COVID-19 vaccine development through its wholly-owned US subsidiary Auro Vaccines, under…
NIBEC, a DBT-supported facility for viral immunogenicity testing inaugurated in Pune
Reportedly, the laboratory has already started associating closely with leading Indian vaccine manufacturing companies and…
Aurobindo Pharma expects Phase I and II trials of COVID-19 vaccine by end of 2020
The company's viral vaccine manufacturing capacity in India would be undertaken in two phases, the first phase would be ready by…
Aurobindo Pharma joins COVID-19 vaccine hunt
The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022
DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate
The clinical trials for the vaccine are likely to start before the year ends
DBT-BIRAC COVID-19 research consortium recommends 70 proposals for funding in vaccines, diagnostics,…
The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options,…
DBT and BIRAC recommend 16 proposals for funding support towards COVID-19 Research Consortium
The duo received around 500 applications from academia and industry
BIRAC announces 16th call for proposals under the Biotechnology Ignition Grant Big Scheme
The scheme enables technology innovators and entrepreneurs to pursue a promising technology idea, and establish and validate POC…
DBT calls for research proposals in new drug development
The goal of the call is to support milestone-driven proposals focussed on lead optimisation and preclinical testing of candidate…